RenovaCare claims patent win against Avita Medical

RenovaCare, Inc., (RCAR), developer of the SkinGun and CellMist System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, said it won against patent challenger Avita Medical in a proceeding at the United States Patent Office (USPTO).

“I’m proud of the cutting-edge technologies developed by our team for the millions that suffer from burns and wounds and deserve access to the very latest in medical innovation,” said Thomas Bold, CEO of RenovaCare.

RenovaCare said Avita’s arguments “were based on old claims and technologies which had already been considered and rejected” and that the USPTO dismissed the challenge and denied a trial sought by Avita.

“Just as we’ve done with this challenge, we’ll aggressively protect our intellectual property while continuing to expand our patent portfolio and enhance shareholder value,” said Bold.